Elevated serum levels of 15(S)-HEPE are associated with asthma, indicating its potential use as a biomarker for asthma; it is also involved in the 15-lipoxygenase (15-LO)-mediated metabolic pathway of eicosapentaenoic acid (EPA), suggesting roles in inflammatory and immunomodulatory processes.